This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Covance And NAFC Sponsor Free Medical Clinic For More Than 1,200 Patients In Dallas, Texas

PRINCETON, N.J., and DALLAS, Oct. 16, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD), a global leader of drug development services, partnered with the National Association of Free and Charitable Clinics (NAFC) to bring an all-day C.A.R.E. (Communities Are Responding Everyday) free clinic and medical care to more than 1,200 uninsured patients from the Dallas-Fort Worth area.

Thirty-one Covance volunteers, including doctors, nurses, clinical and administrative staff from its company locations across the United States, including its Dallas Phase I clinic, joined more than a thousand other local volunteers in coordinating care and treatment for patients at the Dallas Convention Center on Saturday, September 29.

Approximately 900 prescriptions were written to patients, and more than 50 pairs of eyeglasses were provided, mostly to children who had never had vision exams. In addition to an initial examination, patients received point-of-care testing, including electrocardiograms (ECGs), cholesterol blood tests, glucose testing and other diagnostic examinations. Many were treated for chronic conditions, such as diabetes or hypertension.

In addition to the various medical services, patients received free 90-day, mail-order prescriptions. At the end of the clinic, patients were connected with free and charitable clinics in Texas for their follow-up-care appointments.

"Medical care is a critical need in our country today, and is largely unmet because so many people do not have health insurance," said NAFC Executive Director Nicole Lamoureux. "Our C.A.R.E. clinics are funded entirely by sponsors and private citizens, and not one tax dollar is used to pay for them. Thanks to companies like Covance, we are able to provide preventive, primary medical care to these people and connect them to the area's safety-net providers, as well as other available community resources."

According to the NAFC, Texas has the highest rate of uninsured people in the U.S., with approximately 26 percent of residents, many of whom are children, without health insurance. The percentage of uninsured people in the Dallas-Fort Worth area is approximately the same.

"We brought our mission of caring for the people in the communities where we live and work. This effort demonstrated the true spirit of giving and volunteerism among our employees. We came together united with a common purpose – using our medical and clinical skills and expertise to benefit those who needed critical care," said Nigel Brown, Corporate Vice President, Business Development and Strategy, and one of the Covance executives who volunteered at the event. "It was rewarding to see how our efforts made a difference in the Dallas community."

About Covance Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $2 billion, global operations in more than 30 countries, and more than 11,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at

About the NAFC The National Association of Free and Charitable Clinics is the only nonprofit 501(c)(3) organization whose mission is solely focused on the issues and needs of more than 1,200 free and charitable clinics and the people they serve in the United States.

Founded in 2001 and headquartered near Washington, D.C., the NAFC is an effective advocate for the issues and concerns of free and charitable clinics, their volunteer workforce of doctors, dentists, nurses, therapists, pharmacists, nurse practitioners, technicians and other healthcare professionals, as well as the patients served by free and charitable clinics in communities throughout the nation. For more information, go to:

SOURCE Covance Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs